Search results
AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo News· 13 hours agoAbCellera Biologics (ABCL) might move higher on growing optimism about its earnings prospects, which...
Redfin (RDFN) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo News· 13 hours agoOver the past three months, the Zacks Consensus Estimate for thecompany has increased 15.1%. Bottom...
C4 Therapeutics (CCCC) Upgraded to Buy: Here's Why
Zacks via Yahoo News· 13 hours agoTherapeutics. Over the past three months, the Zacks Consensus Estimate for the company has increased 16.2%. Bottom Line Unlike the overly optimistic Wall...
Jack Henry (JKHY) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo News· 13 hours agoOver the past three months, the Zacks Consensus Estimate for thecompany has increased 0.4%. Bottom...
What Makes Teleflex (TFX) a New Buy Stock
Zacks via Yahoo News· 13 hours agoOver the past three months, the Zacks Consensus Estimate for thecompany has increased 0.1%. Bottom Line Unlike the overly optimistic Wall Street analysts...
Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade
Zacks via Yahoo News· 13 hours agoCentury Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects,...
Norwegian Cruise Line (NCLH) Moves to Buy: Rationale Behind the Upgrade
Zacks via Yahoo News· 13 hours agoNorwegian Cruise Line (NCLH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
What Makes Curis (CRIS) a New Buy Stock
Zacks via Yahoo News· 13 hours agoOver the past three months, the Zacks Consensus Estimate for thecompany has increased 9%. Bottom Line Unlike the overly optimistic Wall Street analysts...
What Makes Staffing 360 (STAF) a New Buy Stock
Zacks via Yahoo News· 13 hours agoStaffing 360 (STAF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...
Beam Therapeutics (BEAM) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo News· 13 hours agoBeam Therapeutics (BEAM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
